Belgian biotech developing new treatments for inflammatory diseases.
Industry: Health Care
First Day Return: +20.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/15/2015 |
Offer Price | $42.05 |
Price Range $41.52 - $41.52 | |
Offer Shares (mm) | 6.6 |
Deal Size ($mm) | $275 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/13/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $275 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Mechelen, Belgium |
Founded | 1999 |
Employees at IPO | 417 |
Website www.glpg.com |